[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SG11201705450SA - Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases - Google Patents

Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases

Info

Publication number
SG11201705450SA
SG11201705450SA SG11201705450SA SG11201705450SA SG11201705450SA SG 11201705450S A SG11201705450S A SG 11201705450SA SG 11201705450S A SG11201705450S A SG 11201705450SA SG 11201705450S A SG11201705450S A SG 11201705450SA SG 11201705450S A SG11201705450S A SG 11201705450SA
Authority
SG
Singapore
Prior art keywords
metabolic
bacteria
diseases
compositions
treating
Prior art date
Application number
SG11201705450SA
Inventor
Vos Willem Meindert De
Thi Phuong Nam Bui
Original Assignee
Univ Wageningen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wageningen filed Critical Univ Wageningen
Publication of SG11201705450SA publication Critical patent/SG11201705450SA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/1203Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
SG11201705450SA 2015-01-09 2016-01-08 Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases SG11201705450SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15150701 2015-01-09
PCT/EP2016/050310 WO2016110585A1 (en) 2015-01-09 2016-01-08 Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases

Publications (1)

Publication Number Publication Date
SG11201705450SA true SG11201705450SA (en) 2017-07-28

Family

ID=52434520

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201705450SA SG11201705450SA (en) 2015-01-09 2016-01-08 Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases

Country Status (13)

Country Link
US (2) US11452746B2 (en)
EP (1) EP3242957B1 (en)
KR (1) KR20170103920A (en)
CN (1) CN107405369A (en)
AU (1) AU2016205975B2 (en)
BR (1) BR112017014649A2 (en)
CA (1) CA2973285C (en)
DK (1) DK3242957T3 (en)
ES (1) ES2796355T3 (en)
PL (1) PL3242957T3 (en)
RU (1) RU2017126666A (en)
SG (1) SG11201705450SA (en)
WO (1) WO2016110585A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113730442A (en) 2014-10-31 2021-12-03 潘德勒姆治疗公司 Methods and compositions relating to microbial treatment and diagnosis of disorders
SG11201705450SA (en) 2015-01-09 2017-07-28 Univ Wageningen Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases
AU2017222990A1 (en) 2016-02-25 2018-09-20 Caelus Pharmaceuticals B.V. Compositions and methods for preventing and/or treating vitamin B12 deficiency
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. Methods and compositions for treatment of microbiome-associated disorders
WO2019113023A1 (en) * 2017-12-04 2019-06-13 The BioCollective, LLC Probiotics and methods of use
FR3085963A1 (en) * 2018-09-19 2020-03-20 Novolyze DRY COMPOSITION OF MODEL MICROORGANISMS
NL2024569B1 (en) * 2019-12-24 2021-09-06 Univ Wageningen Bacterium comprising myo-inositol to propionate pathway
RU2734718C1 (en) * 2019-12-31 2020-10-22 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Method of reducing manifestation of non-motor symptoms in patients with parkinson's disease
NL2028324B1 (en) 2021-05-28 2022-12-12 Caelus Pharmaceuticals B V Insulin-sensitizing agent and butyrate-producing bacterium
US20240197662A1 (en) * 2021-12-20 2024-06-20 Tainnovation Inc Methods of and compositions for treating obesity, obesity-related diseases or cancers using a n6-methyllysine/l-lysine mixture

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1835021T3 (en) * 2004-12-28 2011-04-18 Meiji Seika Kaisha New strain assigned anti-disease properties against host and bacterial cell composition
WO2013032328A1 (en) 2011-08-30 2013-03-07 Academisch Medisch Centrum Method for preventing and/or treating insulin resistance
US20140242654A1 (en) 2013-02-26 2014-08-28 Coskata, Inc. Butyrate Producing Clostridium species, Clostridium pharus
US9669059B2 (en) 2013-03-15 2017-06-06 University Of Florida Research Foundation, Incorporated Butyrogenic bacteria as probiotics to treat clostridium difficile
SG11201705450SA (en) 2015-01-09 2017-07-28 Univ Wageningen Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases

Also Published As

Publication number Publication date
EP3242957B1 (en) 2020-03-11
WO2016110585A1 (en) 2016-07-14
PL3242957T3 (en) 2020-10-05
DK3242957T3 (en) 2020-06-02
CN107405369A8 (en) 2018-01-16
CA2973285C (en) 2023-10-17
EP3242957A1 (en) 2017-11-15
US20210069263A1 (en) 2021-03-11
KR20170103920A (en) 2017-09-13
AU2016205975B2 (en) 2021-05-27
CN107405369A (en) 2017-11-28
ES2796355T3 (en) 2020-11-26
AU2016205975A1 (en) 2017-07-27
US11452746B2 (en) 2022-09-27
RU2017126666A (en) 2019-02-12
US20180353552A1 (en) 2018-12-13
BR112017014649A2 (en) 2018-03-13
US11426436B2 (en) 2022-08-30
RU2017126666A3 (en) 2019-07-24
CA2973285A1 (en) 2016-07-14

Similar Documents

Publication Publication Date Title
IL264049A (en) Compounds, compositions, and methods for the treatment of disease
HK1258205A1 (en) Compositions and methods for the treatment of hemoglobinopathies
IL264156A (en) Compounds, compositions, and methods for the treatment of disease
IL289099A (en) Methods for the storage of whole blood, and compositions thereof
HK1256726A1 (en) Carrier-binding agent compositions and methods of making and using the same
IL259246A (en) Compositions of therapeutic substances, methods and uses thereof
SG11201705450SA (en) Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases
ZA202104969B (en) Compositions comprising 15-hepe and methods of using the same
EP3408344A4 (en) Well treatment methods and compositions
PL3524255T3 (en) Composition for the treatment of acne
HK1259372A1 (en) Therapeutic compounds, compositions and methods of use thereof
EP3182989A4 (en) Methods and compositions for the prevention and treatment of disease
EP3310376A4 (en) Modified therapeutic agents and compositions thereof
IL275182A (en) Compositions and methods for the treatment of metabolic conditions
IL266047A (en) Methods and compositions for the treatment of fabry disease
HK1249515A1 (en) Methods and compositions for the prevention and treatment of hearing loss
ZA201902781B (en) Compositions and methods for the treatment of xerostomia
HK1247136A1 (en) Compositions comprising 15-hepe and methods of using the same
IL249640A0 (en) Compositions for the treatment of epistaxis
IL248210A0 (en) Methods and compositions for the treatment of vascular malformation
EP3310377A4 (en) Method of treating crohn's disease
EP3341006A4 (en) Compositions and methods for the treatment of neurodamage
HK1255695A1 (en) Composition and methods for the treatment of blepharoptosis
HK1258999A1 (en) Compositions, methods, and medical compositions for treatment of and maintaining the health of the liver
HK1258765A1 (en) Therapeutic compounds, compositions and methods of use thereof